English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/32563
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorForrester, K.-
dc.contributor.authorAlmoguera, Concepción-
dc.contributor.authorJordano, Juan-
dc.contributor.authorGrizzle, W. E.-
dc.contributor.authorPerucho, M.-
dc.identifier.citationJournal of Tumor Marker Oncology 2 (3) 113-123, (1987)es_ES
dc.descriptionChemicals and CAS Registry Numbers ribonuclease, 59794-03-5, 9001-99-4es_ES
dc.description.abstractWe have recently developed a new method to detect and characterize single base substitutions in transcribed genes which is based on the ability of RNAse A to recognize and cleave single base mismatches in RNA:RNA heteroduplexes. The RNAse A mismatch cleavage assay was applied to screen human colon carcinoma cell lines and primary tumors for the presence of mutant c-K-ras oncogenes. We have determined that the mutant c-K-ras allele is overexpressed and amplified relative to the normal in the SK-CO-1 human colon carcinoma cell line. The oncogene mutation has been characterized by this method as a glycine to valine substitution at codon 12 of the c-K-ras gene. This result was confirmed by cloning and sequencing. We have previously reported that about 40% of primary human colon tumors contain c-K-ras genes mutant at codon 12 (Forrester et al, Nature 327: 298, 1987). We report here the characterization by molecular cloning and sequencing of the mutation in the c-K-ras oncogene from two of these tumors (tumors 3 and 28). We also describe the histopathological characterization of these two tumors and demonstrate, by Southern blot hybridization of NIH3T3 transformants, the simultaneous presence of mutant c-K-ras and N-ras oncogenes in villous adenoma 28. Our results provide evidence for the frequent association of ras somatic mutational activation in the early stages of tumor development in this common type of human cancer.es_ES
dc.description.sponsorshipThis work was supported by NIH grant CA38579 awarded by the National Cancer Institute and by a grant from Toyo Jozo Ltd. Co.es_ES
dc.publisherInternational Academy of Tumor Marker Oncologyes_ES
dc.subjectColon canceres_ES
dc.subjectHuman celles_ES
dc.titleHigh incidence of c-K-ras oncogenes in human colon cancer detected by the RNAse A mismatch cleavage methodes_ES
dc.description.peerreviewedPeer reviewedes_ES
dc.contributor.funderNational Institutes of Health (US)-
dc.contributor.funderNational Cancer Institute (US)-
dc.contributor.funderAsahi Kasei Corporation-
Appears in Collections:(IRNAS) Artículos
Files in This Item:
File Description SizeFormat 
Journal of tumor marker oncology 2 (3) 113-123, 1987.pdf714,42 kBAdobe PDFThumbnail
Show simple item record

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.